Rituximab maintenance after bendamustine-based treatment for follicular lymphoma and mantle cell lymphoma may exert a negative influence on SARS-CoV-2 infection outcomes
Haematologica. 2024 Jul 11.
doi: 10.3324/haematol.2024.285219.
Online ahead of print.